LifeSci Advisors, LLC

Join Senseonics, Incorporated (#SENS) for a virtual KOL event on Fri, Oct. 25 at 11am ET, featuring David T. Ahn, MD (Hoag Medical Group) and Jeff Ciaramita, MD (Mercy), who will join company management to discuss the next-generation Eversense? 365 Continuous Glucose Monitoring (CGM) system, which was recently cleared by the U.S. Food and Drug Administration (FDA) for people with Type 1 and Type 2 diabetes aged 18 years and older. Register here: https://bit.ly/3A46Srh

Join Mineralys Therapeutics, Inc. (#MLYS) for a virtual KOL event on Wed. Oct. 30 at 10am ET, featuring Luke J. Laffin, MD (Cleveland Clinic), James M. Luther, MD, MSCI (Vanderbilt University Medical Center), and Rhian Touyz, MBBCh, MSc (Med), PhD (McGill University Health Centre), who will discuss the unmet medical need in uncontrolled and resistant hypertension (HTN) and the potential for lorundrostat, a highly selective aldosterone synthase inhibitor, to change the treatment paradigm. Register here: https://bit.ly/3A5WyPm

Join scPharmaceuticals (#SCPH) for a KOL webinar on Tues, Oct. 22 at 1pm ET, focused on a nephrologist’s perspective on the use of FUROSCIX for treating fluid overload in heart failure and the potential use in chronic kidney disease (CKD). The event will feature Dr. Michael Aaronson, MD (Lincoln Nephrology and Hypertension, Lincoln, NE). Register here: https://bit.ly/4eHpU5K

TOMORROW! Don't miss the Heidelberg Pharma AG (#HPHA) virtual KOL event at 11am ET, featuring Robert Z. Orlowski, MD, PhD (MD Anderson Cancer Center) and Shambavi Richard, MD (Mount Sinai), who will discuss the current unmet need and treatment landscape in relapsed or refractory multiple myeloma. Register here: https://bit.ly/3XWHMTd

Join us on Tuesday, October 22 at 12pm ET for the latest in our "Lunch with LifeSci" series with Abivax (#ABVX), featuring CEO, Marc de Garidel and CFO, Didier Blondel to discuss the growing need for new safe and durable treatments for inflammatory bowel disease (IBD). Register here: https://bit.ly/4dI6494

Fall events are in full swing! Join us for engaging discussions and KOL insights covering nephrology, oncology, cardiology, dermatology, and more. Don’t miss out on a unique opportunity to learn from industry leaders. Learn more and register here:?https://lnkd.in/eSAFbsXv?#LifeSciEvents #Biotech ? UNITY Biotechnology Heidelberg Pharma AG Lipocine Inc. Aura Biosciences Abivax scPharmaceuticals Pharvaris Erasca, Inc. Senseonics, Incorporated??????????? Mineralys Therapeutics, Inc. Inmagene Biopharmaceuticals

Join Inmagene Biopharmaceuticals for a virtual KOL event on Thurs, Oct. 31 at 10am ET featuring Jonathan Silverberg, MD, PhD, MPH, Maryanne Senna, MD, and Yufang Lu, MD, PhD, who will discuss the potential role of anti-OX40/OX40L monoclonal antibodies (mAbs) in the treatment of atopic dermatitis (AD) and alopecia areata (AA). Register here: https://bit.ly/4esqDYt

Join Valneva in-person or virtually for an investor day in New York on Thurs, Oct 10 at 10am ET featuring speakers from company management, who will discuss the company’s key near- and mid-term growth drivers, including its robust R&D pipeline of potentially first-, only-, or best-in-class vaccine candidates and growing portfolio of revenue-generating vaccines. #VALN #VLA Register here: https://bit.ly/3U1EU6f

Join Heidelberg Pharma AG (#HPHA) for a virtual KOL event on Tues, Oct. 15 at 11am ET, featuring Robert Z. Orlowski, MD, PhD (MD Anderson Cancer Center) and Shambavi Richard, MD (Mount Sinai), who will discuss the current unmet need and treatment landscape in relapsed or refractory multiple myeloma. Register here: https://bit.ly/3XWHMTd

Join Erasca, Inc. (#ERAS) for a virtual investor event on Thurs, Oct. 24 at 8:30 AM ET, where management will provide a research and development (R&D) update on naporafenib (potential first-in-class and best-in-class pan-RAF inhibitor) and the RAS targeting franchise, including ERAS-0015 (potential best-in-class pan-RAS molecular glue) and ERAS-4001 (potential first-in-class and best-in-class pan-KRAS inhibitor). Register here: https://bit.ly/3BpB00I